Skip to main content
CURACHEM Co., ltd. logo

CURACHEM Co., ltd. — Investor Relations & Filings

Ticker · 456190 ISIN · KR7456190008 KO Manufacturing
Filings indexed 65 across all filing types
Latest filing 2025-03-21 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 456190

About CURACHEM Co., ltd.

https://curachem.com/

CURACHEM Co., Ltd., established in 2009, is a global provider specializing in the custom synthesis of isotopically labeled compounds. The company's core services include the synthesis of Carbon-14 (14C) radiolabeled, Tritium (3H) radiolabeled, and stable-isotope labeled compounds. These products are utilized in research and development, particularly for in vivo studies concerning absorption, distribution, metabolism, and excretion (ADME) of new drug candidates. Additionally, CURACHEM offers services in medicinal chemistry and process development, which involve analyzing hit compounds and synthesizing focused libraries. The company functions as a manufacturing laboratory supporting the pharmaceutical and biotechnology sectors.

Recent filings

Filing Released Lang Actions
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding a '주식소각 결정' (Decision to cancel/retire shares) by the company Curachem. It details the number of shares to be cancelled, the method of acquisition (off-market purchase), the schedule, and the board resolution date. This falls under the category of capital changes and share retirement, which is best classified as 'Transaction in Own Shares' (POS) as it relates to the company's action of retiring its own treasury shares.
2025-03-21 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Curachem. It outlines the date, location, agenda items (financial statement approval, director appointment, and remuneration limits), and details regarding the board's resolution. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-03-06 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the scheduling of a General Meeting of Shareholders on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict and provides details on the meeting date and compliance status. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2025-03-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Curachem (주식회사 큐라켐). It includes the meeting date, location, agenda items (financial statement approval, director appointment, remuneration limits), and detailed management information (business overview, financial statements, and board activity). This is a standard proxy statement/notice package sent to shareholders to solicit votes for the upcoming AGM.
2025-03-06 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Curachem. It includes the agenda, meeting details, and management information (such as director appointments and financial statement approval). This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on matters at the upcoming annual general meeting.
2025-03-06 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Curachem. It details the date, location, and specific agenda items (such as financial statement approval, director appointments, and capital reserve adjustments) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2025-03-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.